Sigrid Verhasselt
No current affiliation with UGent
- ORCID iD
-
0000-0002-2744-8951
Show
Sort by
-
Medicinal chemistry and use of myosin II inhibitor (S)-blebbistatin and its derivatives
-
Synthesis of C-ring-modified blebbistatin derivatives and evaluation of their myosin II ATPase inhibitory potency
-
- PhD Thesis
- open access
Development of novel blebbistatin derivatives in the quest for improved non-muscle myosin II inhibitors
(2017) -
- Journal Article
- A1
- open access
Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs
-
- Journal Article
- A1
- open access
Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs
-
- Journal Article
- A1
- open access
Discovery of (S)-3′-hydroxyblebbistatin and (S)-3′-aminoblebbistatin : polar myosin II inhibitors with superior research tool properties
-
Discovery of anti-invasive tools and leads for the study and treatment of metastatic cancer : two case studies
-
Discovery of novel nonmuscle myosin II inhibitors as chemical tools and antimetastatic therapeutics leads
-
Discovery of novel nonmuscle myosin II inhibitors as antimetastatic therapeutics leads and chemical tools
-
Further studies on anti-invasive chemotypes: an excursion from chalcones to curcuminoids